Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choroidal Neovascularization | 4 | 2023 | 34 | 1.790 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2022 | 79 | 1.340 |
Why?
|
| Retinal Pigments | 2 | 2022 | 6 | 1.290 |
Why?
|
| Macular Degeneration | 2 | 2023 | 127 | 1.210 |
Why?
|
| Protein Multimerization | 2 | 2018 | 152 | 1.020 |
Why?
|
| Cone Opsins | 2 | 2022 | 4 | 0.860 |
Why?
|
| Racemases and Epimerases | 1 | 2020 | 12 | 0.680 |
Why?
|
| Apolipoprotein A-I | 1 | 2020 | 89 | 0.670 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2020 | 34 | 0.650 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 131 | 0.610 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2022 | 446 | 0.590 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2017 | 6 | 0.570 |
Why?
|
| Phosphoproteins | 1 | 2020 | 459 | 0.560 |
Why?
|
| Rhodopsin | 1 | 2018 | 69 | 0.560 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 88 | 0.540 |
Why?
|
| Wet Macular Degeneration | 1 | 2017 | 45 | 0.530 |
Why?
|
| Peptides | 1 | 2018 | 862 | 0.430 |
Why?
|
| Mice | 7 | 2023 | 19047 | 0.340 |
Why?
|
| Signal Transduction | 1 | 2022 | 4934 | 0.310 |
Why?
|
| Animals | 8 | 2023 | 36545 | 0.260 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 230 | 0.250 |
Why?
|
| Fluorescein Angiography | 2 | 2023 | 154 | 0.240 |
Why?
|
| Indocyanine Green | 1 | 2023 | 62 | 0.200 |
Why?
|
| Blindness | 1 | 2023 | 76 | 0.200 |
Why?
|
| Light Signal Transduction | 1 | 2022 | 7 | 0.190 |
Why?
|
| Metal Nanoparticles | 1 | 2022 | 59 | 0.190 |
Why?
|
| Electroretinography | 1 | 2022 | 124 | 0.190 |
Why?
|
| Loss of Function Mutation | 1 | 2022 | 161 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4807 | 0.170 |
Why?
|
| Choroid | 1 | 2020 | 41 | 0.170 |
Why?
|
| Acyltransferases | 1 | 2020 | 47 | 0.160 |
Why?
|
| Drug Resistance | 1 | 2020 | 264 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 263 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2020 | 489 | 0.140 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cholesterol | 1 | 2020 | 575 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7216 | 0.140 |
Why?
|
| Protein Structure, Secondary | 1 | 2018 | 256 | 0.140 |
Why?
|
| Opsins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1200 | 0.130 |
Why?
|
| Retina | 1 | 2020 | 502 | 0.130 |
Why?
|
| Proteolysis | 1 | 2017 | 199 | 0.130 |
Why?
|
| Macrophages | 1 | 2020 | 711 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2018 | 290 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 535 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2539 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2020 | 4015 | 0.090 |
Why?
|
| Aged | 2 | 2020 | 21772 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1594 | 0.080 |
Why?
|
| Male | 2 | 2020 | 66093 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2022 | 54 | 0.050 |
Why?
|
| Gold | 1 | 2022 | 57 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2022 | 121 | 0.050 |
Why?
|
| Bevacizumab | 1 | 2022 | 79 | 0.050 |
Why?
|
| Female | 2 | 2020 | 71893 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2022 | 150 | 0.050 |
Why?
|
| Rabbits | 1 | 2022 | 729 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2022 | 220 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2022 | 709 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 556 | 0.040 |
Why?
|
| Middle Aged | 1 | 2017 | 29394 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 569 | 0.030 |
Why?
|
| Humans | 2 | 2020 | 134084 | 0.030 |
Why?
|